Last reviewed · How we verify

NCT03024749: SUIT-SAVM

Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas

Status unknown Last updated 6 June 2017
What this trial tests

trial in Spinal Cord Vascular Diseases in 380 participants. Status unknown.

Timeline
1 December 2016
Primary endpoint
31 December 2018
31 December 2019

Quick facts

Lead sponsorHongqi Zhang, MD
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment380
Start date1 December 2016
Primary completion31 December 2018
Estimated completion31 December 2019
Sites1 location across China

Conditions studied

Sponsor

Hongqi Zhang, MD

Who can join

Eligibility, any sex, with Spinal Cord Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spinal arteriovenous fistulas (AVFs) and arteriovenous malformations (AVMs) are complex neurosurgical lesions that are very challenging to manage. Spinal vascular malformations account for 3%-4% of all intradural spinal cord mass lesions. Over the last few decades our understanding of these lesions has dramatically increased thanks to neuroimaging technology (e.g. spinal angiography and indocyanine green angiography). Various treatment modalities including conservative observation, endovascular embolization, microsurgical resection, radiation therapy, and combined therapies have been reported. The treatment for these AVMs and AVFs depends on their location, the type of malformation, the area of the spine involved, and the condition of the patient at the time of treatment. Due to the rarity of these spinal vascular lesions, reports of their management and outcomes have been limited to small series and case reports. And the rates of obliteration and outcomes are not satisfactory, especially the spinal AVMs. Spinal vascular lesions are rare but represent a formidable challenge for the treating neurosurgeon.The purpose of this study is to establish multimodality treatment mode and evaluate the anatomical cure rate and functional preservation rate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hongqi Zhang, MD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03024749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing